METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers? early trial launches
Disease control Not yet recruitingThis early-phase trial tests a new drug called ITC-6146RO in about 102 adults with advanced or metastatic cancers (prostate, lung, breast, or other solid tumors) that have not responded to standard treatments. The study has two parts: first, finding the safest dose, then checking…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1 • Sponsor: IntoCell, Inc • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New pill shows promise in battle against advanced prostate cancer
Disease control Not yet recruitingThis study tests a new oral drug, TQB3201, for people with advanced prostate cancer that has spread and no longer responds to standard hormone therapy. The drug works by targeting and breaking down a key protein that fuels cancer growth. The trial aims to find safe doses and chec…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC